Current status and value of testing antiphospholipid antibody in patients with acute ischemic stroke: a retrospective single-center study in China
- 14 September 2023
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (3) , 1121-1128
Abstract
Testing for antiphospholipid antibodies (aPL) is useful to determine the cause of ischemic stroke in young and female patients. However, the clinical relevKeywords
This publication has 26 references indexed in Scilit:
- Guidance for the evaluation and treatment of hereditary and acquired thrombophiliaJournal of Thrombosis and Thrombolysis, 2016
- Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndromeAutoimmunity, 2014
- Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control studyThe Lancet Neurology, 2009
- Hypercoagulation testing in ischemic stroke.Archives of Pathology & Laboratory Medicine, 2007
- Antiphospholipid antibodies and strokeCurrent Cardiology Reports, 2004
- Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic StrokeJAMA, 2004
- Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002Lupus, 2003
- Antiphospholipid Antibodies and Stroke in Young WomenStroke, 2002
- Diagnostic Testing for Coagulopathies in Patients With Ischemic StrokeStroke, 2000
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993